Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDP.L Regulatory News (IDP)

  • There is currently no data for IDP

Director/PDMR Shareholding

24 Dec 2021 12:41

RNS Number : 8006W
InnovaDerma PLC
24 December 2021
 

InnovaDerma PLC

("InnovaDerma" or the "Company")

Director/PDMR shareholding

 

InnovaDerma (LSE: IDP), a leading digitally focused UK beauty brand developer, announces that it was notified on 24 December 2021, Mark Ward, Non-executive Director has purchased 376,799 Ordinary Shares of €0.10 each in the Company at an average price of 35.0 pence per Ordinary Share.

Following the purchase, Mark Ward now holds a total of 5,049,076 Ordinary Shares representing approximately 18.44% of the issued share capital of the Company.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Further enquiries  

InnovaDerma  

Blake Hughes 

c/o TB Cardew 

finnCap Ltd  

Geoff Nash/Kate Bannatyne 

Alice Lane - Corporate Broking 

+44 (0)207 220 0500 

www.finncap.com 

TB Cardew  

Shan Shan Willenbrock/ 

Olivia Rosser 

+ 44 (0)7775 848537 

+ 44 (0)20 7930 0777 

innovaDerma@tbcardew.com

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mark Ward

2. 

Reason for the Notification

 

a)

Position/status

Non-executive Director

b)

Initial notification/Amendment

Initial notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

InnovaDerma PLC

 

b)

LEI

213800WRAP6W8VDL6B38

 

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the Financial instrument, type of instrument

€0.10 each ("Ordinary Shares")

Identification code

IDP GB00BT9PTW34

 

b)

Nature of the transaction

Purchase of Ordinary Shares

 

c)

Price(s) and volume(s)

Volume - 376,799 Ordinary Shares

Average Price - 35 pence per Ordinary Share

 

d)

Aggregated information:

Aggregated volume

Price

 

See 4c) above

 

e)

Date of the transaction

23 December 2021

 

f)

Place of the transaction

London Stock Exchange, Main Market

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUSOURAKUUUAA
Date   Source Headline
12th Jan 20227:00 amRNSTrading Update
6th Jan 20222:06 pmRNSSecond Price Monitoring Extn
6th Jan 20222:01 pmRNSPrice Monitoring Extension
4th Jan 20227:00 amRNSAcquisition of Remaining Shareholding - Skinny Tan
24th Dec 202112:44 pmRNSHolding(s) in Company
24th Dec 202112:41 pmRNSDirector/PDMR Shareholding
23rd Dec 20211:22 pmRNSNotice of AGM and Posting of Annual Report
20th Dec 20219:10 amRNSFinal Results
6th Dec 20217:00 amRNSJV established to accelerate growth of Prolong
22nd Oct 20217:00 amRNSExtension to Annual Report & Accounts Publication
12th Oct 20217:00 amRNSAppointment of Skinny Tan brand ambassador
16th Sep 202111:17 amRNSDirector/PDMR Shareholding
15th Sep 20217:00 amRNSHolding(s) in Company
13th Sep 20216:24 pmRNSHolding(s) in Company
7th Sep 202110:35 amRNSDirector/PDMR Shareholding
2nd Sep 20217:00 amRNSCorporate Update
8th Jul 20217:00 amRNSTrading Statement
5th Jul 20217:00 amRNSChange of Auditor
11th May 20216:15 pmRNSDirector/PDMR Shareholding
7th May 202111:05 amRNSSecond Price Monitoring Extn
7th May 202111:00 amRNSPrice Monitoring Extension
4th May 20215:12 pmRNSHolding(s) in Company
29th Apr 202112:24 pmRNSResult of Open Offer and General Meeting
29th Apr 20217:00 amRNSGeneral Meeting and Trading Statement
19th Apr 20214:41 pmRNSSecond Price Monitoring Extn
19th Apr 20214:35 pmRNSPrice Monitoring Extension
16th Apr 202111:00 amRNSDirector/PDMR Shareholding
12th Apr 20216:19 pmRNSPublication of Prospectus
12th Apr 20217:00 amRNSExpected Timetable of Events
31st Mar 20217:00 amRNSInterim Results
22nd Mar 20212:25 pmRNSNotice of Results, Prospectus and General Meeting
24th Feb 20215:09 pmRNSForm 8.3 - Offeree Innovaderma
24th Feb 20214:47 pmRNSForm 8.3 - InnovaDerma PLC
23rd Feb 20211:51 pmRNSForm 8.3 - InnovaDerma PLC
22nd Feb 20214:48 pmRNSForm 8.3 - Innovaderma
19th Feb 20214:13 pmRNSForm 8.3 - Innovaderma PLC
18th Feb 20217:00 amRNSForm 8.3 - InnovaDerma PLC
17th Feb 20215:23 pmRNSForm 8.3 - InnovaDerma PLC
17th Feb 202112:37 pmRNSForm 8.3 - InnovaDerma
16th Feb 20216:23 pmRNSForm 8.3 - InnovaDerma PLC
16th Feb 202112:33 pmRNSForm 8.3 - InnovaDerma
16th Feb 202110:52 amRNSForm 8.3 - Innovaderma Plc
16th Feb 202110:06 amRNSForm 8.3 - Innovaderma PLC
16th Feb 20219:05 amBUSForm 8.3 - INNOVADERMA PLC - AMENDMENT
15th Feb 20216:12 pmRNSForm 8.3 - InnovaDerma
15th Feb 20215:03 pmRNSForm 8.3 - InnovaDerma Plc
15th Feb 20215:02 pmRNSHolding(s) in Company
15th Feb 20214:47 pmRNSForm 8 (OPD) - InnovaDerma plc
15th Feb 20213:40 pmRNSForm 8.3 - InnovaDerma PLC
15th Feb 20212:54 pmRNSForm 8.3 - InnovaDerma PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.